Scarica l'app Stockscreener
3.56
5.82%
-0.22
Dopo l'orario di chiusura:
3.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$3.78
Aprire:
$3.75
Volume 24 ore:
63,416
Relative Volume:
0.39
Capitalizzazione di mercato:
$184.04M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-3.1228
EPS:
-1.14
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
+0.56%
1M Prestazione:
-16.43%
6M Prestazione:
+21.50%
1 anno Prestazione:
-56.27%
Intervallo 1D:
$3.54
$3.755
Intervallo di 1 settimana:
$3.42
$3.80
Portata 52W:
$2.03
$8.41
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Confronta SGHT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.56 | 184.58M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
What analysts say about Sight Sciences Inc. stockExceptional portfolio growth - Autocar Professional
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Is Sight Sciences Inc. a good long term investmentDynamic capital growth - Autocar Professional
What drives Sight Sciences Inc. stock priceAccelerated capital growth - Autocar Professional
Sight Sciences Inc. Stock Analysis and ForecastRapid growth opportunities - jammulinksnews.com
What makes Sight Sciences Inc. stock price move sharplyFree Stock Market Forums - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of “Hold” by Brokerages - Defense World
Wall Street Zen Downgrades Sight Sciences (NASDAQ:SGHT) to Sell - Defense World
Sight Sciences (NASDAQ:SGHT) Stock Price Expected to Rise, Morgan Stanley Analyst Says - Defense World
The Analyst Verdict: Sight Sciences In The Eyes Of 4 Experts - Nasdaq
How Sight Sciences Inc. stock performs during market volatilityFree Join Group - Newser
Why Sight Sciences Inc. stock attracts strong analyst attentionBreakout Setup Scanner - Newser
Sight Sciences CLO Hayden sells $38k in SGHT stock - Investing.com
Sight Sciences Executives Sell Shares to Cover Tax Liabilities - TradingView
Wall Street Zen Upgrades Sight Sciences (NASDAQ:SGHT) to “Hold” - Defense World
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World
Sight Sciences (SGHT) Price Target Raised by Piper Sandler | SGHT Stock News - GuruFocus
Piper Sandler raises Sight Sciences price target to $4 on technology outlook - Investing.com India
Sight Sciences (SGHT) Sees Price Target Increase Amid Market Recovery | SGHT Stock News - GuruFocus
Sight Sciences price target raised to $4 from $3.50 at Piper Sandler - TipRanks
Sight Sciences Uses RWE To Refine Patient Segmentation And Reverse A Medicare Ruling For OMNI - Clinical Leader
Millennium Management LLC Invests $464,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight Sciences director Encrantz buys $381,957 in common stock - Investing.com India
Sight Sciences director Encrantz buys $381,957 in common stock By Investing.com - Investing.com Nigeria
sight sciences appoints new board member and holds annual meeting By Investing.com - Investing.com South Africa
sight sciences appoints new board member and holds annual meeting - Investing.com India
Sight Sciences Holds Annual Stockholders Meeting - TipRanks
ProShare Advisors LLC Makes New $36,000 Investment in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World
Sight sciences director Encrantz buys $376,429 in stock By Investing.com - Investing.com Nigeria
Sight sciences director Encrantz buys $376,429 in stock - Investing.com Australia
Sight Sciences Independent Chairman Acquires 7.8% More Stock - simplywall.st
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of “Hold” from Analysts - Defense World
Sight sciences director Staffan Encrantz buys $451k in stock By Investing.com - Investing.com UK
Sight sciences director Staffan Encrantz buys $451k in stock - Investing.com Australia
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):